Omega Healthcare Investors, Inc.

NYSE:OHI Stock Report

Market Cap: US$14.4b

Omega Healthcare Investors Valuation

Is OHI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of OHI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: OHI ($47.4) is trading below our estimate of future cash flow value ($89.42)

Significantly Below Future Cash Flow Value: OHI is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for OHI?

Key metric: As OHI is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for OHI. This is calculated by dividing OHI's market cap by their current earnings.
What is OHI's PE Ratio?
PE Ratio24.5x
EarningsUS$572.03m
Market CapUS$14.42b

Price to Earnings Ratio vs Peers

How does OHI's PE Ratio compare to its peers?

The above table shows the PE ratio for OHI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average96.5x
DOC Healthpeak Properties
164.6x22.65%US$11.5b
CTRE CareTrust REIT
27.9x13.99%US$9.0b
VTR Ventas
161.1x27.22%US$40.8b
SBRA Sabra Health Care REIT
32.3x12.08%US$5.0b
OHI Omega Healthcare Investors
24.5x5.40%US$14.4b

Price-To-Earnings vs Peers: OHI is good value based on its Price-To-Earnings Ratio (24.5x) compared to the peer average (90x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does OHI's PE Ratio compare vs other companies in the Global Health Care REITs Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
OHI 24.5xIndustry Avg. 27.9xNo. of Companies5PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: OHI is good value based on its Price-To-Earnings Ratio (24.5x) compared to the Global Health Care REITs industry average (28.1x).

Price to Earnings Ratio vs Fair Ratio

What is OHI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OHI PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio24.5x
Fair PE Ratio32.9x

Price-To-Earnings vs Fair Ratio: OHI is good value based on its Price-To-Earnings Ratio (24.5x) compared to the estimated Fair Price-To-Earnings Ratio (32.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst OHI forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$47.40
US$48.06
+1.40%
8.07%US$59.00US$43.00n/a16
Feb ’27US$43.88
US$47.13
+7.40%
6.27%US$54.00US$43.00n/a16
Jan ’27US$44.34
US$46.69
+5.29%
5.70%US$50.00US$40.00n/a16
Dec ’26US$45.82
US$46.06
+0.53%
5.97%US$50.00US$40.00n/a16
Nov ’26US$42.03
US$44.27
+5.32%
5.86%US$50.00US$40.00n/a15
Oct ’26US$42.31
US$43.87
+3.68%
5.58%US$50.00US$40.00n/a15
Sep ’26US$42.57
US$42.57
+0.0034%
5.73%US$46.00US$37.00n/a14
Aug ’26US$39.95
US$40.86
+2.27%
7.22%US$46.00US$37.00n/a14
Jul ’26US$36.67
US$40.27
+9.81%
7.67%US$46.00US$36.00n/a15
Jun ’26US$37.00
US$40.27
+8.83%
7.67%US$46.00US$36.00n/a15
May ’26US$38.56
US$40.80
+5.81%
7.96%US$46.00US$36.00n/a15
Apr ’26US$38.07
US$40.87
+7.35%
7.73%US$46.00US$37.00n/a15
Mar ’26US$36.84
US$41.07
+11.47%
7.83%US$46.00US$37.00n/a15
Feb ’26US$37.06
US$42.33
+14.23%
7.98%US$49.00US$37.00US$43.8815
Jan ’26US$37.85
US$42.60
+12.55%
7.61%US$49.00US$37.00US$44.3415
Dec ’25US$40.61
US$42.47
+4.57%
8.24%US$49.00US$35.00US$45.8215
Nov ’25US$41.20
US$41.07
-0.32%
9.92%US$49.00US$35.00US$42.0315
Oct ’25US$40.39
US$39.50
-2.20%
8.60%US$46.00US$34.00US$42.3114
Sep ’25US$39.54
US$38.69
-2.14%
7.20%US$44.00US$34.00US$42.5713
Aug ’25US$36.70
US$34.50
-5.99%
6.99%US$39.00US$30.00US$39.9514
Jul ’25US$33.97
US$33.36
-1.80%
7.40%US$38.00US$28.00US$36.6714
Jun ’25US$32.33
US$32.86
+1.63%
6.29%US$36.00US$28.00US$37.0014
May ’25US$30.69
US$32.79
+6.83%
7.40%US$37.00US$28.00US$38.5614
Apr ’25US$31.82
US$32.79
+3.03%
7.40%US$37.00US$28.00US$38.0714
Mar ’25US$31.00
US$32.53
+4.95%
8.00%US$37.00US$28.00US$36.8415
Feb ’25US$29.52
US$32.47
+9.98%
7.19%US$36.00US$28.00US$37.0615
US$48.06
Fair Value
1.4% undervalued intrinsic discount
16
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/13 06:07
End of Day Share Price 2026/02/13 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Omega Healthcare Investors, Inc. is covered by 34 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Amanda SweitzerBaird
David RodgersBaird
Steven ValiquetteBarclays